RxDoctor Payments Data

Joseph Sales, MD

Otolaryngology/Facial Plastic Surgery · Jonesboro, ARNPI 1851366140

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations.

$2,434in general payments, 2019–2025

Across 110 payments — averaging $22.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$529
  • Intersect ENT, Inc.$358
  • Regeneron Healthcare Solutions, Inc.$349
  • Sanofi$260
  • Phathom Pharmaceuticals, Inc.$205
  • Organogenesis Inc.$128
  • plus $603 from 12 others

What the payments were for

  • Food & beverage$2,434100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in Arkansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$198,521
Medicare patients
690
Services billed
6,946

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Famotidine527$4,881
Fluticasone Propionate190$2,193
Omeprazole244$2,058
Azelastine Hcl103$1,973
Pantoprazole Sodium113$1,886
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth13$1,551
Esomeprazole Magnesium82$1,439
Ipratropium Bromide44$1,379
Ofloxacin42$1,324
Levocetirizine Dihydrochloride97$1,057
Clotrimazole13$438
Doxycycline Hyclate41$386
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip27$328
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$273
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav23$266

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Jonesboro

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →